Orogen Royalties Announces 34% Expansion of Gold Resources at Merlin Project

Orogen Royalties’ Expanded Silicon Project Sees Significant Gold Discovery by AngloGold Orogen Royalties Inc. (TSX.V:OGN, OTCQX:OGNRF), a mineral exploration company, is thrilled to share the latest developments at its Expanded Silicon project in Nevada, USA. The project’s owner, AngloGold Ashanti NA (“AngloGold”), has recently announced an updated Inferred Resource of 12.1 million ounces gold at…

Read More

“Unveiling Stryker Corporation’s Q4 2024 Earnings: A Comprehensive Conference Call Transcript”

Stryker Corporation Q4 2024 Earnings Conference Call January 28, 2025 – 4:30 PM ET Company Participants: Kevin Lobo – Chairman, CEO & President Andy Pierce – Group President of MedSurg & Neurotechnology Jason Beach – Vice President, Finance and Investor Relations Glenn Boehnlein – Vice President, Chief Financial Officer During the Fourth Quarter 2024 Stryker…

Read More

Get Ready to Geek Out: Unity Biotechnology’s Latest Clinical Data to be Unveiled at ASRS’s 40th Annual Scientific Meeting!

Breaking News Alert: A Closer Look at UNITY Biotechnology, Inc. What’s the Buzz About? Exciting developments are happening in the world of biotechnology with the recent announcement from UNITY Biotechnology, Inc. Based in South San Francisco, this innovative company is making waves with their groundbreaking research and development efforts. Who is UNITY Biotechnology, Inc.? UNITY…

Read More

“Attention Shareholders: Don’t Miss Out on Your Rights! Contact Levi & Korsinsky by February 24, 2025 for Caribou Biosciences Inc.”

Financial Fireworks in the Biotech World: Caribou Biosciences, Inc. Faces Securities Lawsuit What’s the Buzz in the Stock Market? Hey there, fellow investors! Have you heard the latest news swirling around the financial grapevine? Well, buckle up because it’s about to get juicy. Levi & Korsinsky, LLP dropped a bombshell announcement regarding Caribou Biosciences, Inc….

Read More

Uniquely Quirky and Captivating: A Blog-Friendly Rewrite of ‘Accesswire’s Article on Maximizing Reader Engagement’

Welcome to the Eccentric World of Allarity Therapeutics, Inc. A Lawsuit Unveiled On October 1, 2024, Pomerantz LLP made a groundbreaking announcement regarding a class action lawsuit filed against Allarity Therapeutics, Inc. The lawsuit, filed in the United States District Court for the Southern District of New York, addresses alleged violations of federal securities laws…

Read More